Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CNC vs GSK✓SelectedUSD · GSKCNC vs GSK performance historyLatest closeAs of-2.97%11/17
Stock and ETF performance explorer

CNC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+152.8%
GSK return
+104.0%
Excess return
+48.8%
Maximum drawdown
-74.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.0%-2.3%-0.6%-1.9%
7D+3.4%-3.0%+6.4%+4.8%
30D+4.9%+0.4%+4.6%+4.9%
3M+12.6%-1.2%+13.8%+13.2%
6M+24.5%+0.9%+23.6%+23.0%
YTD+76.3%+4.0%+72.3%+68.8%
1Y+95.7%+7.3%+88.4%+84.4%
3Y-0.1%+57.1%-57.2%-24.7%
5Y-4.8%+43.0%-47.7%-26.1%
10Y+152.8%+103.1%+49.7%+60.6%
All+152.8%+104.0%+48.8%+60.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling